NCT03392545View on ClinicalTrials.gov

Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1)

PHASE1UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

April 1, 2020

Study Completion Date

June 1, 2020

Conditions
High Grade GliomaGlioblastomaGlioma of BrainstemGlioma, Malignant
Interventions
COMBINATION_PRODUCT

Combined immune adjuvants and radiation

24 hours before the radiation, patients will be administrated poly I:C or CAR-T or TCR-T intratumorally and receive granulocyte macrophage colony stimulating factor 5 days after the radiation.

Trial Locations (1)

100050

RECRUITING

Beijing Tiantan Hospital, Beijing

Sponsors

Collaborators (1)

Duke University
All Listed Sponsors
collaborator

Duke University

OTHER

lead

Beijing Tiantan Hospital

OTHER